Completed PHASE4 INTERVENTIONAL NCT00412932

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension

A Prospective, Open Label, Single Arm Study to Evaluation the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Elderly Patients With Hypertension

Sponsor: Daiichi Sankyo

Conditions Hypertension

Interventions Olmesartan medoxomil Olmesartan medoxomil/hydrochlorothiazide

Updated 10 times since 2017 Last updated: Sep 15, 2009 Started: Dec 31, 2006 Primary completion: Apr 30, 2008 Completion: Apr 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Hypertension and is currently completed. Daiichi Sankyo leads this study, which shows 10 recorded versions since 2006 — indicating substantial longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

10 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE4
Sep 2024 — Sep 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Mar 2024 — Jul 2024 [monthly]

Completed PHASE4
Apr 2022 — Mar 2024 [monthly]

Completed PHASE4

▶ Show 5 earlier versions

Jan 2021 — Apr 2022 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Sep 2017 — Jun 2018 [monthly]

Completed PHASE4
Feb 2017 — Sep 2017 [monthly]

Completed PHASE4
Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Daiichi Sankyo

Data source: Daiichi Sankyo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Auburn, United States , Baltimore, United States , Berlin, United States , Birmingham, United States , Charlotte, United States , Chicago, United States , Cincinnati, United States , Corpus Christi, United States , Farmington, United States , Florissant, United States and 19 more locations